Skip to main navigation Skip to search Skip to main content

Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia

  • Andrew W. Silagy
  • , Margaret L. Hannum
  • , Roy Mano
  • , Kyrollis Attalla
  • , Joseph R. Scarpa
  • , Renzo G. DiNatale
  • , Julian Marcon
  • , Jonathan A. Coleman
  • , Paul Russo
  • , Kay S. Tan
  • , Gregory W. Fischer
  • , Patrick J. McCormick
  • , A. Ari Hakimi
  • , Joshua S. Mincer*
  • *Corresponding author for this work
  • Memorial Sloan-Kettering Cancer Center
  • University of Melbourne
  • Cornell University

Research output: Contribution to journal › Letter › peer-review

32 Scopus citations
Original languageEnglish
Pages (from-to)e402-e404
JournalBritish Journal of Anaesthesia
Volume125
Issue number5
DOIs
StatePublished - Nov 2020
Externally publishedYes

Funding

FundersFunder number
National Cancer InstituteP30CA008748

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • analgesia
    • cancer
    • nephrectomy
    • oncological outcomes
    • opioids
    • renal cell carcinoma

    Cite this